Eton Pharmaceuticals, Inc. (ETON) vs Supernus Pharmaceuticals, Inc. (SUPN)

Eton Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Supernus Pharmaceuticals, Inc. is the larger, with a market value of $2.5B against $1.7B — 1.5× the size. Supernus Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Eton Pharmaceuticals, Inc. trades at 123×. Eton Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 81.5% against 24.9%. Eton Pharmaceuticals, Inc. has the higher net margin (12.0% vs −13.2%) and the higher return on invested capital (21.4% vs −12.4%). Across the 18 metrics below, Eton Pharmaceuticals, Inc. leads on 9 and Supernus Pharmaceuticals, Inc. on 9.